Gestational Diabetes and BMI: Causes, Weight Before Pregnancy and GLP-1 Timing

Gestational diabetes is high blood sugar that develops during pregnancy in someone without diabetes before. It affects roughly one in six pregnancies worldwide, and overweight and obesity are among its main risk factors ^[1]. Compared with women of normal weight, women with obesity have about 3.6 times the odds of developing it ^[2]. Blood sugar usually returns to normal after birth, but the risk of type 2 diabetes later is about ten times higher ^[6]. This review covers what causes gestational diabetes, how weight before and between pregnancies affects it, what treatment and prevention achieve, and what is and is not known about GLP-1 drugs before and after pregnancy.

The honest summary

• Weight before pregnancy is a strong risk factor. Odds of gestational diabetes were about 2.1 times higher with overweight, 3.6 times with obesity and 8.6 times with severe obesity ^[2].
• Weight change between pregnancies matters. Gaining weight between pregnancies raised the odds in the next pregnancy; losing weight lowered them, most clearly in women who started with a BMI over 25 ^[3].
• Diet and exercise during pregnancy may lower the risk a little. The pooled estimate was a 15% reduction, which did not quite reach statistical certainty ^[4].
• Treating gestational diabetes prevents serious complications. In a landmark trial, serious problems for the baby fell from 4% to 1% ^[5].
• The long-term risk is type 2 diabetes, and lifestyle change or metformin roughly halved it in women with prior gestational diabetes and prediabetes ^[7].
• GLP-1 drugs are not a pregnancy treatment. Studies of stopping them before pregnancy conflict: some link recent use to more weight gain and more gestational diabetes ^[11][12], a meta-analysis found no clear increase ^[14].

What causes gestational diabetes?

In most cases, gestational diabetes happens when the insulin-producing cells of the pancreas cannot keep up on a background of long-standing insulin resistance, and blood sugar rises ^[1]. That is why the main risk factors are overweight and obesity, older age at pregnancy, and a family history of diabetes ^[1]. Researchers still do not fully understand the molecular steps involved, which is one reason there is no reliable way to prevent it ^[1].

It raises the chance of a large baby and a difficult birth, and over the longer term it is linked to type 2 diabetes and heart disease in the mother and to obesity and diabetes risk in the child ^[1].

Pre-pregnancy BMI and gestational diabetes risk

A meta-analysis of 20 cohort studies measured how much weight before pregnancy raises the risk ^[2]. Compared with women of normal weight, the odds of gestational diabetes were 2.14 times higher with overweight, 3.56 times with obesity and 8.56 times with severe obesity. The pattern held regardless of study design or how common gestational diabetes was among normal-weight women in each study.

Does losing weight before pregnancy lower the risk?

No trial has randomly assigned women to lose weight before pregnancy and measured gestational diabetes. The closest evidence comes from women's weight change between one pregnancy and the next. A 2021 meta-analysis of 13 observational studies found that weight gain between pregnancies raised the odds of gestational diabetes in the next pregnancy (OR 1.56), while weight loss lowered them (OR 0.83) ^[3]. The benefit of weight loss was larger in women whose BMI was above 25 before the first pregnancy (OR 0.58).

These studies cannot prove that weight loss itself caused the lower risk, but the direction is consistent with what is known about insulin resistance. The window between pregnancies is also when many women carry weight gained in pregnancy; how that weight changes in the first postpartum year is covered in postpartum weight loss and GLP-1 drugs.

Diet and exercise during pregnancy

A Cochrane review of 19 randomized trials with 6,633 women found a possible 15% lower risk of gestational diabetes with combined diet and exercise programs during pregnancy (risk ratio 0.85), though the result fell just short of statistical significance ^[4]. Women in these programs gained slightly less weight in pregnancy, by about 0.9 kg. Pregnancy is not a time for weight-loss diets; these programs aimed at healthy eating, activity and appropriate weight gain.

Why treating gestational diabetes matters

In the ACHOIS trial, 1,000 women with gestational diabetes were randomly assigned to treatment (dietary advice, blood sugar monitoring and insulin if needed) or routine care ^[5]. Serious complications for the baby, defined as death, shoulder dystocia, bone fracture or nerve palsy, occurred in 1% of the treated group versus 4% of the routine-care group. Treated women had more inductions of labor (39% versus 29%), but cesarean rates were the same, and at three months after birth they reported less depression and better quality of life.

After pregnancy: type 2 diabetes risk

A 2020 meta-analysis of 20 studies with more than 1.3 million women found that those with a history of gestational diabetes were about 9.5 times more likely to develop type 2 diabetes than women whose pregnancies had normal blood sugar ^[6]. Across the studies, about 10% to 16% of women with prior gestational diabetes went on to develop type 2 diabetes during follow-up. The authors stressed the early years after pregnancy as the time to intervene.

Prevention works. In the Diabetes Prevention Program, 350 women with a history of gestational diabetes and prediabetes were randomly assigned to intensive lifestyle change, metformin or placebo ^[7]. Both lifestyle change and metformin cut the rate of diabetes by about 50% compared with placebo. On placebo, these women developed diabetes at a 71% higher rate than women with similar blood sugar but no history of gestational diabetes.

GLP-1 drugs and gestational diabetes

Before pregnancy

GLP-1 drugs are an obvious tool for losing weight before a pregnancy, but they have to be stopped first. The Wegovy label states that weight loss offers no benefit to a pregnant patient and may cause fetal harm, and advises stopping semaglutide at least 2 months before a planned pregnancy because of its long half-life ^[9]. The Zepbound label gives no planned-pregnancy window; it says to stop tirzepatide when a pregnancy is recognized, and to switch from oral birth control to a non-oral method, or add a barrier method, for 4 weeks after starting and after each dose increase ^[10]. The details by drug are in the GLP-1 pregnancy washout guide and Mounjaro and pregnancy.

What happens after stopping is the open question. In a US academic health-system study of 448 pregnancies with GLP-1 use in the years before or early in pregnancy, matched with 1,344 unexposed pregnancies, users gained 3.3 kg more during pregnancy and had more gestational diabetes (20% versus 15%), preterm birth and high blood pressure in pregnancy ^[11]. A national US records study of semaglutide found the same pattern in women who stopped before pregnancy and those exposed into early pregnancy, with higher odds of excess weight gain and gestational diabetes than non-users, and no difference between the two user groups ^[12]. Its authors read this as weight regain after stopping rather than an effect of the drug on the pregnancy.

A 2026 meta-analysis of ten studies with 8,325 exposed pregnancies reached a different answer: it found no clearly detectable increase in gestational diabetes, birth defects, miscarriage or other outcomes after GLP-1 exposure in the six months before a positive test ^[14]. The authors cautioned that this does not establish safety. All of these studies compare women who chose to use a GLP-1 drug with women who did not, and BMI before treatment may differ in ways matching cannot fully fix.

During pregnancy

GLP-1 drugs are not used to treat gestational diabetes. The labels say to stop them when a pregnancy is recognized ^[9][10]. In the ACHOIS trial, treatment meant diet, monitoring and insulin when needed ^[5].

After pregnancy

GLP-1 drugs are being studied to prevent type 2 diabetes after gestational diabetes. In a randomized trial, 104 women with overweight or obesity and prior gestational diabetes took liraglutide 1.8 mg or placebo for a year ^[8]. Liraglutide improved glucose tolerance and lowered weight by about 3.9 kg more than placebo, and the share with prediabetes fell from 64% to 10% versus 50% on placebo. After a one-week break from the drug, the glucose benefit disappeared. A 2026 review judged the evidence for GLP-1 drugs in this group limited and mostly from small, short studies, with the first large trial of a more potent GLP-1 drug under way ^[13]. Breastfeeding affects when these drugs can be started; see postpartum weight loss and GLP-1 drugs.

Practical guidance

• If your BMI is over 25 and you are planning a pregnancy, weight loss beforehand is linked to lower gestational diabetes risk, though it has not been tested in a trial ^[3].
• On semaglutide, the label says stop at least 2 months before a planned pregnancy ^[9]; for tirzepatide, set the date with your prescriber ^[10].
• Plan for the months after stopping. Rapid regain is linked to more weight gain in pregnancy and possibly more gestational diabetes ^[11][12].
• If you develop gestational diabetes, treat it. Treatment sharply reduces serious complications for the baby ^[5].
• After the birth, get your blood sugar checked and keep checking it. Lifestyle change or metformin halves the risk of type 2 diabetes in women with prior gestational diabetes and prediabetes ^[7].